A large language model-based AI system deployed at Cleveland Clinic effectively identified diverse, eligible participants for a rare disease clinical trial through EMR screening.
Key Details
- 1Cleveland Clinic and Dyania Health used an AI system (Synapsis AI) to pre-screen for a Phase 3 trial in transthyretin amyloid cardiomyopathy (ATTR-CM).
- 2In one week, the AI reviewed 1,476 records and identified 46 potential matches; 29/30 AI-identified matches were missed by traditional methods.
- 3The AI achieved 96.2% accuracy for 7,700 trial-specific questions and a 99% negative predictive value (NPV) in excluding ineligible patients.
- 4AI-assisted recruitment led to a more diverse patient cohort, with 36.6% Black participants versus 7.1% via routine screening.
- 5Only 60% of AI-identified patients had heart failure specialist care, versus 92.8% found by traditional methods, showing improved outreach.
- 6The system used both structured EMR data and NLP to analyze clinical notes and provided auditable inclusion/exclusion justifications.
Why It Matters

Source
EurekAlert
Related News

AI-Simulation Approach Achieves 90% Faster Brain MRI with Minimal Data
A simulation-based AI method can reconstruct brain MRI scans with only 10% of the usual data, greatly reducing scan times.

Mayo Clinic Showcases Imaging AI and Early Cancer Detection Advances at ASCO 2026
Mayo Clinic researchers will present over 30 studies at ASCO 2026, highlighting new advances in imaging AI, data science, and early cancer detection.

ACM Honors 3D Generative AI and NeRF Innovators With Technical Awards
ACM recognized researchers for breakthroughs in wireless standards, artificial intelligence, and 3D generative AI, including major advances in neural radiance fields impacting computer vision and medical imaging.